Insider · CIK 0001765476
Christopher Ross Macleod
Files at ZOMDF (Zomedica Corp.). First filing -, latest -.
In brief
Christopher Ross Macleod files SEC Form 4 as director at ZOMDF (Zomedica Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher Ross Macleod has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ZOMDF Zomedica Corp. | AGrant or award Stock Appreciation Rightderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 18, 2025 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | AGrant or award Stock Appreciation Rightsderivative | +1,823,107 | $0.00 | $0 | 1,823,107 | Nov 13, 2024 |
Questions about Christopher Ross Macleod
Answered from the filings on this page, as of the latest one.
Is Christopher Ross Macleod buying or selling?
Christopher Ross Macleod has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher Ross Macleod's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher Ross Macleod has 0.
Where does Christopher Ross Macleod file Form 4?
Christopher Ross Macleod has filed Form 4 at ZOMDF (Zomedica Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.